Publications by authors named "Gilbert Block"

Claim this Profile
S
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial.
George Maynard, Ramakrishnan Kannan, Jian Liu, Weiwei Wang, Tu Kiet T Lam, Gilbert Block

Lancet Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.
Robert G Miller, Gilbert Block, Jonathan S Katz, Richard J Barohn, Vidhya Gopalakrishnan

Neurol Neuroimmunol Neuroinflamm· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.
Robert G Miller, Rongzhen Zhang, Gilbert Block, Jonathan Katz, Richard Barohn

Amyotroph Lateral Scler Frontotemporal Degener· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.
Leon J Thal, Steven H Ferris, Louis Kirby, Gilbert A Block, Christopher R Lines

Neuropsychopharmacology· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telephone screening for amnestic mild cognitive impairment.
Christopher R Lines, Kathleen A McCarroll, Richard B Lipton, Gilbert A Block,

Neurology· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis